Fecal microbiota transplantation augments 5-fluorouracil efficacy in pancreatic cancer via gut microbiota modulation
Frontiers in Microbiology · 25.09.2025 · 16
DOI: 10.3389/fmicb.2025.1548027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 25.09.2025. Verfasst von Rui Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pancreatic cancer is a highly aggressive malignancy with limited therapeutic options due to rapid tumor progression and poor prognosis. Fecal Microbiota Transplantation (FMT) has emerged as a promising approach to modulate gut microbiota, potentially enhancing the efficacy of conventional treatments.
Objectives
This study evaluates the combined effects of FMT and 5-fluorouracil (5FU) on gut microbiota composition, pancreatic tumor growth, and systemic immune responses in a murine model.
Methods
One hundred female C57BL/6 mice aged 6–8 weeks were randomly divided into five groups ( n = 20 each): Sham, Model, FMT, 5FU, and FMT + 5FU. Pancreatic tumors were induced via orthotopic implantation of Pan02 cells. FMT was administered orally (0.2 g fecal material) three times per week, starting 2 weeks before tumor implantation. 5FU was administered intraperitoneally at 25 mg/kg body weight twice weekly, beginning one-week post-tumor implantation. Gut microbiota was analyzed via 16S rRNA gene sequencing of fecal samples after 10-week cell implantation. Tumor volumes were measured, and serum cytokine levels were assessed. Short-chain fatty acids (SCFAs) in blood and feces using gas chromatography–mass spectrometry (GC–MS).
Results
The FMT + 5FU group exhibited the smallest average tumor volume, significantly smaller than the Model ( p < 0.0001) and 5FU groups ( p = 0.005). FMT alone reduced tumor volume compared to the Model group ( p < 0.0001). Gut microbiota analysis revealed increased α diversity in the FMT group compared to the Model group ( p < 0.0001). The FMT + 5FU group showed a significant reduction in cytokine levels, including TNF- α ( p = 0.0001) and IL-6 ( p = 0.012) and increased IL-10 level ( p < 0.001), compared to the Model group. Plasma and fecal SCFA concentrations were significantly higher in both FMT and FMT + 5FU groups relative to the Model group ( p < 0.001). Additionally, the FMT + 5FU group had the highest survival rate (50%) after 10-week cell implantation, compared to the Model group (15%).
Conclusion
FMT significantly enhances the efficacy of 5FU in reducing pancreatic tumor growth through gut microbiota modulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
- Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Zitieren
APA
Li, R., Hu, Y., Liu, Y., & Tan, X. (2025). Fecal microbiota transplantation augments 5-fluorouracil efficacy in pancreatic cancer via gut microbiota modulation. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1548027
Vancouver
Li R, Hu Y, Liu Y, Tan X. Fecal microbiota transplantation augments 5-fluorouracil efficacy in pancreatic cancer via gut microbiota modulation. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1548027
BibTeX
@article{Li2025,
author = {Li, Rui and Hu, Yaoyuan and Liu, Yixian and Tan, Xiaodong},
title = {Fecal microbiota transplantation augments 5-fluorouracil efficacy in pancreatic cancer via gut microbiota modulation},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1548027}
}
EUVIMED